Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Aurobindo Pharma Ltd ( (IN:AUROPHARMA) ) is now available.
Aurobindo Pharma Ltd has announced the incorporation of a new wholly owned subsidiary, Aurobindo Pharma Chile SpA, through its existing subsidiary Helix Healthcare B.V. This strategic move aims to expand Aurobindo’s pharmaceutical business into the Chilean market, enhancing its global footprint. The incorporation involves a 100% cash subscription to the share capital, with no governmental or regulatory approvals required, indicating a smooth entry into the Chilean market.
More about Aurobindo Pharma Ltd
Aurobindo Pharma Ltd is a prominent player in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of generic pharmaceuticals and active pharmaceutical ingredients. The company has a significant market presence and aims to expand its operations globally.
Average Trading Volume: 59,508
Technical Sentiment Signal: Hold
Current Market Cap: 638.9B INR
See more data about AUROPHARMA stock on TipRanks’ Stock Analysis page.